Duration of humoral immunity to common viral and vaccine antigens

被引:912
作者
Amanna, Ian J.
Carlson, Nichole E.
Slifka, Mark K.
机构
[1] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR 97006 USA
[2] Oregon Hlth & Sci Univ, Dept Publ Hlth & Preventat Med, Div Biostat, Portland, OR USA
关键词
D O I
10.1056/NEJMoa066092
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Maintenance of long-term antibody responses is critical for protective immunity against many pathogens. However, the duration of humoral immunity and the role played by memory B cells remain poorly defined. Methods We performed a longitudinal analysis of antibody titers specific for viral antigens (vaccinia, measles, mumps, rubella, varicella-zoster virus, and Epstein-Barr virus) and nonreplicating antigens (tetanus and diphtheria) in 45 subjects for a period of up to 26 years. In addition, we measured antigen-specific memory B cells by means of limiting-dilution analysis, and we compared memory B-cell frequencies to their corresponding serum antibody levels. Results Antiviral antibody responses were remarkably stable, with half-lives ranging from an estimated 50 years for varicella-zoster virus to more than 200 years for other viruses such as measles and mumps. Antibody responses against tetanus and diphtheria antigens waned more quickly, with estimated half-lives of 11 years and 19 years, respectively. B-cell memory was long-lived, but there was no significant correlation between peripheral memory B-cell numbers and antibody levels for five of the eight antigens tested. Conclusions These studies provide quantitative analysis of serologic memory for multiple antigens in subjects followed longitudinally over the course of more than one decade. In cases in which multiple exposures or repeated vaccinations were common, memory B-cell numbers did not correlate with antibody titers. This finding suggests that peripheral memory B cells and antibody-secreting plasma cells may represent independently regulated cell populations and may play different roles in the maintenance of protective immunity.
引用
收藏
页码:1903 / 1915
页数:13
相关论文
共 42 条
[11]   Cutting edge: Long-term B cell memory in humans after smallpox vaccination [J].
Crotty, S ;
Felgner, P ;
Davies, H ;
Glidewell, J ;
Villarreal, L ;
Ahmed, R .
JOURNAL OF IMMUNOLOGY, 2003, 171 (10) :4969-4973
[12]   Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis [J].
Edwards, JCW ;
Szczepanski, L ;
Szechinski, J ;
Filipowicz-Sosnowska, A ;
Emery, P ;
Close, DR ;
Stevens, RM ;
Shaw, T .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (25) :2572-2581
[13]   LONG-TERM IMMUNITY TO TETANUS - A STATISTICAL EVALUATION AND ITS CLINICAL IMPLICATIONS [J].
GOTTLIEB, S ;
MCLAUGHLIN, FX ;
LEVINE, L ;
LATHAM, WC ;
EDSALL, G .
AMERICAN JOURNAL OF PUBLIC HEALTH AND THE NATIONS HEALTH, 1964, 54 (06) :961-971
[14]   Duration of antiviral immunity after smallpox vaccination [J].
Hammarlund, E ;
Lewis, MW ;
Hansen, SG ;
Strelow, LI ;
Nelson, JA ;
Sexton, GJ ;
Hanifin, JM ;
Slifka, MK .
NATURE MEDICINE, 2003, 9 (09) :1131-1137
[15]   RUBELLA ANTIBODY PERSISTENCE AFTER IMMUNIZATION [J].
HERRMANN, KL ;
HALSTEAD, SB ;
WIEBENGA, NH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1982, 247 (02) :193-196
[16]   Safety and pharmacokinetic evaluation of intravenous vaccinia immune globulin in healthy volunteers [J].
Hopkins, RJ ;
Kramer, WG ;
Blackwelder, WC ;
Ashtekar, M ;
Hague, L ;
La Roche, SDW ;
Berezuk, G ;
Smith, D ;
Leese, PT .
CLINICAL INFECTIOUS DISEASES, 2004, 39 (06) :759-766
[17]  
IPSEN J, 1946, J IMMUNOL, V54, P325
[18]  
Leyendeckers H, 1999, EUR J IMMUNOL, V29, P1406, DOI 10.1002/(SICI)1521-4141(199904)29:04<1406::AID-IMMU1406>3.0.CO
[19]  
2-P
[20]   PROSPECTIVE STUDY OF SERUM ANTIBODY AND PROTECTION AGAINST SMALLPOX [J].
MACK, TM ;
THOMAS, DB ;
NOBLE, J .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1972, 21 (02) :214-+